Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

Acta Neuropsychiatrica
Bruna PanizzuttiOlivia M Dean

Abstract

This study aimed to explore effects of adjunctive treatment with N-acetyl cysteine (NAC) on markers of inflammation and neurogenesis in bipolar depression. This is a secondary analysis of a placebo-controlled randomised trial. Serum samples were collected at baseline, week 8, and week 32 of the open-label and maintenance phases of the clinical trial to determine changes in interleukin (IL)-6, IL-8, IL-10, tumour necrosis factor-α (TNF-α), C-reactive protein (CRP) and brain-derived neurotrophic factor (BDNF) following adjunctive NAC treatment, and to explore mediation and moderator effects of the listed markers. Levels of brain-derived neurotrophic factor (BDNF), tumour necrosis factor-α (TNF-α), C-reactive protein (CRP), interleukins (IL) -6, 8, or 10 were not significantly changed during the course of the trial or specifically in the open-label and maintenance phases. There were no mediation or moderation effects of the biological factors on the clinical parameters. The results suggest that these particular biological parameters may not be directly involved in the therapeutic mechanism of action of adjunctive NAC in bipolar depression.

References

Feb 1, 1991·Clinical Pharmacokinetics·M R Holdiness
Oct 9, 2002·Archives of General Psychiatry·Helena Chmura KraemerW Stewart Agras
Dec 9, 2008·Behavioural Brain Research·Olivia DeanMaarten van den Buuse
Mar 2, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Marcelo M NascimentoBjörn Anderstam
Dec 2, 2010·Journal of Psychiatry & Neuroscience : JPN·Olivia DeanMichael Berk
Jul 2, 2011·Journal of Affective Disorders·Michael BerkGin S Malhi
Dec 23, 2011·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Pedro V MagalhãesMichael Berk
Feb 2, 2013·Trends in Pharmacological Sciences·Michael BerkOlivia M Dean
Mar 16, 2013·The Australian and New Zealand Journal of Psychiatry·Pedro Vieira da Silva MagalhãesMichael Berk
Apr 27, 2013·Biochimica Et Biophysica Acta·Yuval SamuniMichael Berk
Apr 29, 2014·Journal of Affective Disorders·Menan A RabieRania El-Sawy Mahmoud
Sep 22, 2015·Lancet·Iria GrandeEduard Vieta
May 4, 2016·The Journal of Clinical Psychiatry·Brisa S FernandesMichael Berk
Nov 3, 2016·Expert Opinion on Drug Metabolism & Toxicology·Alessandro MinariniGian Maria Galeazzi
Nov 2, 2016·Psychiatry and Clinical Neurosciences·Ekaterina SigitovaJiří Raboch

❮ Previous
Next ❯

Citations

Sep 6, 2019·Nutrients·Deanna M Minich, Benjamin I Brown
Feb 23, 2021·Expert Opinion on Pharmacotherapy·Ahmad Sleem, Rif S El-Mallakh
Mar 25, 2021·British Journal of Pharmacology·Irena SmagaMałgorzata Filip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.